Posts tagged "Collaboration"

LifeQ and Medibio to Deliver Scalable Mental Wellness Diagnostic and Management Tools

January 4th, 2017 Posted by News Story, Press Release 0 comments on “LifeQ and Medibio to Deliver Scalable Mental Wellness Diagnostic and Management Tools”

The platform only requires inputs from wrist-based wearables to arm people with information to continuously monitor and manage their mental wellbeing

January 04, 2017: LAS VEGAS, Medibio and LifeQ today announced at CES a partnership towards delivering mental wellness diagnostic and management solutions to a wide range of users through insurance and corporate programs. Mental health and wellness is a significant issue globally. Left untreated, chronic stress and depression can result in serious health conditions including anxiety, insomnia, high blood pressure and a weakened immune system, contributing to the development of chronic diseases, such as cardiovascular disease, diabetes, depression, and anxiety disorders.

This partnership combines LifeQ’s systems biology modeling and unique suite of information streams with Medibio’s 15 years of mental health research and objective test for mental wellness. Together, Medibio and LifeQ will deliver a solution that enables stakeholders, including payers, providers and wellness companies, to benefit from a completely new range of products and services.
Leveraging LifeQ’s groundbreaking systems biology based approached, which enables the extraction of a range of accurate measures and metrics from wrist based wearables, Medibio’s solution will be extended through continuous measurement and made available at scale.

Distribution of these outputs will be further enhanced and enabled by LifeQ’s Information Platform that seamlessly connects an ecosystem of domain experts, all of whom will now be able to access and use these information outputs. LifeQ is dedicated to promoting the proliferation of physiological data to eliminate boundaries and enhance quality of life globally. From powering health information platforms that bring prevention and efficient care to the world, to technology inside the best wearable body monitoring devices, LifeQ technology is empowering people to redefine the way they engage with their unique human biology.

“Medibio skills are hugely complementary to LifeQ’s and it is exactly the type of specialist company LifeQ set out to enable with our ability to deliver highly accurate physiological information. We believe this partnership will have the potential for a groundbreaking shift in the current approach to diagnosis and management of mental wellness – now one of the single biggest cost factors in the global health burden,” said Riaan Conradie President and Co-Founder LifeQ.

In commenting on the partnership, Sean Mathieson, the Chief Operating Officer of Medibio said, “We are excited by the potential of LifeQ’s innovative approach to digital health and wellness. We can see business opportunities and synergies across a number of our target market segments.”

About LifeQ

LifeQ is pioneering a new front in the effort to bring meaningful digital health and wellness insights and platforms to market. By leveraging in-house multidisciplinary skills and partnering with other analytics providers, LifeQ is able to create and bring together the vital science and technology platforms needed to bridge the industry gap between scalable and cutting edge data acquisition technologies and personalized health and lifestyle-related information platforms. The resulting data and platforms will be made easily scalable and accessible to global insurance and corporate wellness providers, pharmaceutical suppliers, genomics researchers and others via APIs into LifeQ’s deidentification and switching protocol. Taken as a whole, the LifeQ platform is creating exciting new opportunities for an ever-expanding array of health and wellness opportunities, building sustainable value for investors and partners, and enhancing the lives of people everywhere.

About Medibio

Medibio (ASX: MEB), is a medical technology company that has developed an objective test to assist in the diagnosis of depression, chronic stress and other mental health disorders. Based on research conducted over 15 years at the University of Western Australia, the test utilizes patented (and patent pending) circadian heart rate variability and cloud based proprietary algorithms delivering a quantifiable measure to assist in clinical diagnosis. Medibio’s depression diagnostic is being validated in clinical studies undertaken by The University of Ottawa, among others. The clinical trials will support Medibio’s application to become the first FDA approved, objective, and evidence based approach to the diagnosis of mental health disorders. Medibio’s technology also provides an objective method for the assessment of stress and mental wellbeing that can be translated to the workplace stress/wellbeing market, wearable technology and App market. Located in Melbourne (Vic) Medibio is listed on the Australian Securities Exchange Ltd.

Garmin and LifeQ Join to Deliver Connected Health Solution

June 13th, 2016 Posted by News Story, Press Release 0 comments on “Garmin and LifeQ Join to Deliver Connected Health Solution”

A deep collaboration to supercharge connected health

June 13, 2016: OLATHE, Kan. Garmin International Inc., a unit of Garmin Ltd. and LifeQ today announced a deep collaboration to ensure health data generated from its wearable devices delivers on current and future high efficacy information requirements of the health insurance and corporate wellness ecosystems. By combining the market-leading wearable devices of Garmin with the unique on-device and cloud based biomathematical capabilities of LifeQ the two companies will deliver a joint digital health solution as part of the broader health ecosystem.

This highly integrative collaboration enables personalized and continuous tracking of physiological parameters related to sleep, stress, activity and nutrition as well as risk metrics as required by the insurance and pharmaceutical industry (such as cardiovascular age). The data enables health insurers to further analyze population risk factors to define new products and services that are more personalized and seek to lower the cost of health care delivery across the world. In addition, these personalized data streams provide the necessary insights and context to assist consumers in making smarter health and lifestyle decisions for themselves and their families.

With its world leading computational systems biology expertise, LifeQ ensures a unique scientific approach to the delivery of individual physiological information from wearable and other data sources. Combined with the patented LifeQ biomathematical engine, a range of physiological measures that are currently inaccessible, costly and invasive are now available via LifeQ’s API for ecosystem members to integrate with.

Quote from Riaan Conradie (Co-Founder & COO LifeQ):

“The connected health and insurance ecosystem of the future will be propelled forward to a whole new level through rapid delivery of personalized physiological information that is now possible due to rapid advances in hardware and analytics capabilities,” said Riaan Conradie Co-Founder and COO of LifeQ. “By combining LifeQ’s computational systems biology based on-device and cloud based analytics products with Garmin’s world leading devices we will jointly open up a range of high value personalized solutions to the health and life insurance industry. We are very excited about this preferred partnership.”

LifeQ and Garmin have a joint passion for data generation and delivery to enable health transformation services, and this collaboration will strengthen the ecosystem in the rapidly growing connected health market.

“Garmin is excited to team up with LifeQ to enable the advancement of the healthcare industry,”
said Allison Swelin, manager of Garmin Health sales and marketing. “Garmin wearables are being used across a number of healthcare applications as a tool to help monitor things like activity levels, all-day heart rate and sleep.”

unnamed-1

unnamed

unnamed-3

unnamed-2

Analog Devices and LifeQ Collaborate to Improve Effectiveness of Body Monitoring Devices in Health Management

April 21st, 2016 Posted by News Story, Press Release 0 comments on “Analog Devices and LifeQ Collaborate to Improve Effectiveness of Body Monitoring Devices in Health Management”

NORWOOD, Mass.—Analog Devices, Inc. (ADI) today announced a collaboration with LifeQ to develop technology that will make it possible for non-invasive body monitoring devices to provide highly accurate physiological data that currently is only available through the use of expensive, invasive and hard-to-access equipment. By combining the market-leading engineering and innovation of Analog Devices with the unique bio-mathematical capabilities of LifeQ, the two companies plan to design sensors that enable personalized, continuous and accurate tracking of physiological parameters such as heart rate, sleep phases, sleep quality, blood lactate, 24-hour calorie intake as well as stress markers such as salivary cortisol. Monitoring this type of data can increase early detection of emergency conditions and diseases in at-risk patients.

“The development of smart wearable sensors is essential to supercharge the next generation of non-invasive body monitoring solutions,” said James Doscher, general manager, Industrial and Business Healthcare Group, Analog Devices. “ADI offers the semiconductor expertise and LifeQ provides the bio-mathematical understanding needed to develop sensors that can make body monitoring devices even more effective in preventing, predicting and managing diseases. This, in turn, will impact how doctors and patients share information, interact, and make decisions about patient care. Patients can have greater access to vital data about their own bodies and be more involved in their overall health and wellness.”

“LifeQ’s collaboration with ADI will enable sensor solutions that meet a higher and wider standard, including new industry benchmarks such as the latest Android Wear requirements,” said Riaan Conradie, co-founder and chief operating officer, LifeQ. “Our goal is to deliver high-value physiological data to ecosystem partners who are serving consumer lifestyle, corporate wellness and health insurance markets.”

ADI’s comprehensive portfolio of linear, mixed-signal, MEMS (microelectromechanical systems) and digital processing technologies are used in healthcare diagnostics, clinical monitoring equipment, life science and medical instrumentation, and health and wellness device designs.

With its world leading computational systems biology expertise, LifeQ ensures a unique approach to the construction and acquisition of information from bio-sensors. Combined with the patented LifeQ bio-mathematical engine, a range of physiological measures that are currently inaccessible, costly and invasive are now available both through wearable devices and via LifeQ’s API.

About LifeQ

LifeQ is a health informatics company that has recently released a cloud based bio-mathematical engine and API.   LifeQ’s bio-mathematical engine can ingest various data streams (continuous, periodic, episodic and/or static physiological data streams) to construct a highly personalized and accurate digital representation of an individual’s unique physiology.  For the first time physiological measures that are currently inaccessible, costly and invasive are now available via LifeQ’s platform and ecosystem of partners who will be able to deliver highly valuable personalized services in a wide range of market verticals such as lifestyle, corporate wellness, health and life insurance and clinical applications. Visit www.lifeq.com

About Analog Devices

Analog Devices (NASDAQ: ADI) designs and manufactures semiconductor products and solutions.  We enable our customers to interpret the world around us by intelligently bridging the physical and digital with unmatched technologies that sense, measure and connect. Visit http://www.analog.com.